化妆品功效评价(Ⅵ)——化妆品人体功效评价的实验设计

doi:10.13218/j.cnki.csdc.2018.06.003

摘要/Abstract

摘要： 概述了化妆品人体功效评价实验设计的概念、基本要素和基本原则,介绍了常用实验设计类型和实验设计要点,提供了人体功效评价实验方案设计的思路,有助于提高研究者制定实验设计方案的水平。

Abstract: The concept,basic elements,and basic principles of experimental design of cosmetics human efficacy evaluation were summarized.The commonly used types and key points of experimental design were introduced.The new idea of the design of cosmetics human efficacy evaluation protocol was proposed,in order to improve the ability of researchers to make a reliable experiment protocol.

Key words: cosmetics, efficacy evaluation, clinical study, experimental design

中图分类号:

TQ658

盘瑶, 赵华. 化妆品功效评价(Ⅵ)——化妆品人体功效评价的实验设计[J]. 日用化学工业, 2018, 48(6): 314-321.

PAN Yao, ZHAO Hua. Efficacy evaluation of cosmetics (Ⅵ) Experimental design of cosmetics human efficacy evaluation[J]. China Surfactant Detergent & Cosmetics, 2018, 48(6): 314-321.

参考文献

[1] European Commission.Commission regulation (EU) No 655/2013 laying down common criteria for the justification of claims used in relation to cosmetic products [J].Official Journal of the European Union,2013,L190:31-34.
[2] National Institutes for Food and Drug Control.Notice on publicly soliciting the “Guidelines for the evaluation of cosmetic efficacy claims” [EB/OL].(2018-01-24) [2018-05-21].http://www.nicpbp.org.cn/CL0901/10514.html.
[3] Liu Wen-qing.Design of experiments [M].Beijing:Tsinghua University Press,2005.
[4] Yang Jun-ying,Zhang Gui-qin.Experimental design scheme and selection of statistical analysis methods [J].Chinese Journal of Physical Medicine and Rehabilitation,2001(6):57-60.
[5] Moher D,Hopewell S,Schulz K F,et al.Consort 2010 explanation and elaboration:updated guidelines for reporting parallel group randomised trials [J].BMJ,2010,340:869.
[6] Li Jing.Clinical trial design:randomized controls [J].China Circulation Journal,2017(11):1126-1127.
[7] Hu Wan,Sun Yan-song,Hu Liang-ping.How to follow the four principles of experimental design in physiological research [J].Chinese Journal of Applied Physiology,2017(1):89-93.
[8] Fang Ji-qian.Statistical methods for biomedical research [M].Beijing:Higher Education Press,2007.
[9] Li Li-ming,Ye Dong-qing,Zhan Si-yan.Epidemiology [M].Beijing:People's Medical Publishing House,2008.
[10] Wang Qi,Hu Liang-ping.The concept and foundation of experimental design [J].Pharmaceutical Care and Research,2010(1):5-9.
[11] Tang Long-mei,Yan Li-na,Wang Li-qin.Commonly used experimental design methods in medical research [J].Clinical Meta,2013(2):120-177.
[12] Li Zi-an,Sun Chang-lei,Zhu Li-ping.Clinical efficacy test and analysis of ginseng anti-aging products [J].Chemicals for Daily Use,2015(12):48-51.
[13] Ma Yan-feng,Bai Xiao-yun,Bao Jing-lin,et al.Comparative study on moisturizing effects of 2 face masks [J].Guangdong Chemical Industry,2013(17):77-78.
[14] Jia Li-li,Li Yuan-hong,Wu Yan,et al.Clinical observation on white-ning effect and safety of resveratrol [J].Chinese Beauty Medicine,2012(9):1340-1342.
[15] Xie Wen-jian,Jia Fang,Lv Ying,et al.Study on the evaluation of human effectiveness of four moisturizing skin care products [J].Spice Flavor Cosmetics,2015(2):40-42.
[16] Ma Yan-feng,Bai Xiao-yun,Niu Wen-xia,et al.A preliminary study on the instant efficacy of a moisturizing facial mask [J].Spice Flavor Cosmetics,2014(5):38-40.
[17] Chan A W,Tetzlaff J M,Gotzsche P C,et al.SPIRIT 2013 explanation and elaboration:guidance for protocols of clinical trials [J].BMJ,2013,346:7586.
[18] Fey M F.Clinical trial design in oncology:selection of patients [J].Lancet Oncol,2004,5(12):760.
[19] Zhang Qiang,Meng Ping,Shan Ai-lian.Some thoughts on the inclusion and exclusion criteria in drug clinical trial schemes [J].Chinese Journal of Clinical Pharmacology,2017(2):99-101.
[20] Gui Yu-liang,Chen Zun,Tian Guo-xiang,et al.Reflections on the design of clinical trial schemes for clinical research design schemes [J].Chinese Journal of Evidence-Based Cardiovascular Medicine,2017(6):641-643.
[21] State Food and Drug Administration.Cosmetic safety technical specification (2015 Edition) [Z].Beijing:2015.
[22] Li Yun,Sun Qiu-ning,Yang Rong-ya,et al.Therapeutic effect observation of 862 patients with facial sensitive skin treated with soothing special cream [J].Practical Journal of Dermatology,2015(2):85-88.
[23] Jiang Xian,Ji Ran,Lu Hua,et al.A randomized controlled study of the effects of Liquan Spring Soothing Spray on the adjuvant therapy of recurrent dermatitis in female faces [J].Journal of Sichuan University (Medical Science Edition),2008(2):343-344.
[24] Rothman K J.Epidemiology.An introduction [M].Oxford:Oxford University Press,2012.
[25] Wan Jin-jin,Liu Rui-xue,Leng Qun-ying.Study on the efficacy of a sensitive skin cream [J].Chemicals for Daily Use,2017(11):24-28.
[26] Ye Cong-xiu,Lai Wei,Yi Jin-ling,et al.Study on evaluation method of lip moisturizing effectiveness of lip cosmetics [J].Chinese Beauty Medicine,2010(1):75-77.
[27] Xia Xue,Guo Yi-rong,Chen Xue,et al.Research on the body effect of a new multi-effect cushion powder cream [J].Chemicals for Daily Use,2017(1):36-40.
[28] Shen Ning,Hu Liang-ping.How to strictly abide by the principle of four principles of experimental design in mental health research [J].Sichuan Mental Health,2016(4):295-302.
[29] Xie Xiao-yuan,Wang Ran,Lai Wei,et al.Discussion on the evaluation method of antidandruff cosmetic effect [J].Chinese Beauty Medicine,2010(1):72-74.
[30] Gebski V.Clinical trial design in oncology:assessment of outcomes [J].Lancet Oncol,2004,5(12):761-763.
[31] Wang Chun-xiao,Zhao Hua.Evaluation of cosmetic effectiveness (Ⅱ):scientific support for moisturizing effectiveness [J].Daily Chemical Industry,2018(2):67-72.
[32] Zhao Hua,Wang Nan.Evaluation of cosmetic effectiveness (Ⅲ):scientific support for whitening effects [J].Daily Chemical Industry,2018(3):129-133.
[33] Li Cheng-tong,Zhao Hua.Evaluation of cosmetic effectiveness (Ⅳ):scientific support for delaying skin aging [J].Daily Chemical Industry,2018(4):188-195.
[34] Schulz K F,Grimes D A.Sample size calculations in randomised trials:mandatory and mystical [J].Lancet,2005,365(9467):1348-1353.
[35] Han Mei,Yang Guo-yan,Wang Yu-yi,et al.Chinese medicine clinical trial scheme design ideas and report specification [J].Chinese Journal of Integrated Traditional Chinese and Western Medicine,2014(8):907-910.
[36] World Medical Association Declaration of Helsinki.Recommendations guiding physicians in biomedical research involving human subjects [J].JAMA,1997,277(11):925-926.
[37] Wang Xiao-xia,Li Yu-min.Grasp the clinical research plan to do a new drug clinical trial [J].Chinese Medicine and Clinical,2012(1):48-49.
[38] Ambrosius W T.Topics in biostatistics [M].New Jersey:Humana Press,2007.
[39] Wu Yan,Zhong Shao-min,Joe Kaczvinsky,et al.Effect of nicotinamide and N-acetylglucosamine on pigmentation [J].Clinical Journal of Dermatology,2007(10):628-631.
[40] Brocklehurst P,Hoare Z.How to design a randomised controlled trial [J].Br Dent J,2017,222(9):721-726.
[41] Hou Wei,Zhang Jie-chen,Tian Wei-wei,et al.Randomized,double-blind,self-controlled study on chloasma cream in the treatment of chloasma [J].Chinese Beauty Medicine,2011(5):792-795.
[42] Bigby M,Gadenne A S.Understanding and evaluating clinical trials [J].J Am Acad Dermatol,1996,34(4):555-590,591-593.
[43] Alosh M,Fritsch K,Soukup M,et al.Clinical trials and statistical analyses:what should dermatologists look for in a report ? [J].Dermatol Ther,2009,22(3):199-203.
[44] Calvert M,Kyte D,Mercieca-bebber R,et al.Guidelines for inclusion of patient-reported outcomes in clinical trial protocols:the SPIRIT-PRO extension [J].JAMA,2018,319(5):483-494.
[45] Kawashima M,Nagare T,Doi M.Clinical efficacy and safety of benzoyl peroxide for acne vulgaris:Comparison between Japanese and Western patients [J].J Dermatol,2017,44(11):1212-1218.
[46] ICH.Guideline for good clinical practice E6 (R2) [EB/OL].(2016-11-09)[2018-05-21].http://www.ich.org/fileadmin/Public-Web-Site/ICH-Products/Guidelines/Efficacy/E6/E6_R2_Step_4_2016_1109.pdf.
[47] China Food and Drug Administration.General office of the general administration of China publicly solicits opinions on the “Quality control regulations for drug clinical trials (revised draft)” [EB/OL].(2016-12-01)[2018-05-21].http://samr.cfda.gov.cn/WS01/CL0778/166981.html.
[48] Grimes D A,Hubacher D,Nanda K,et al.The good clinical practice guideline:a bronze standard for clinical research [J].Lancet,2005,366(9480):172-174.
[49] Sheng Xiao-yan,Xu Jun-yu,Liang Yan,et al.Formulation and management of standard operating procedures for phase I drug clinical trials [J].Chinese Journal of Clinical Pharmacology,2017(14):1357-1359.
[50] Liu Huan,Yang Li.Analysis of influencing factors of clinical trial quality [J].Chinese Journal of New Drugs,2018(6):678-681.